Functional effects of agents differentially selective to noradrenergic or serotonergic systems

Psychological Medicine

Volumn 32, Issue 3, 2002, Pages 517-524

  Tranter, R ^a   Healy, H ^a   Cattell, D ^a   Healy, D ^a  

^a BANGOR UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PSYCHOTROPIC AGENT; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; AVOIDANCE BEHAVIOR; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; DRUG PREFERENCE; DRUG SELECTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; INSOMNIA; JAW DISEASE; MAINTENANCE THERAPY; MALE; MOOD; NAUSEA; NORADRENERGIC SYSTEM; NORMAL HUMAN; PERSONALITY TEST; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SELF EVALUATION; SEROTONINERGIC SYSTEM; SEXUAL DYSFUNCTION; THROAT DISEASE; VOLUNTEER;

ADRENERGIC UPTAKE INHIBITORS; ADULT; AFFECT; BRAIN; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; PERSONALITY INVENTORY; QUALITY OF LIFE; RECEPTORS, ADRENERGIC; RECEPTORS, SEROTONIN; SELF ASSESSMENT (PSYCHOLOGY); SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 0036222699     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291701005086     Document Type: Article

References (26)

1. Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale
2. Dopamine D-2 receptor density and personal detachment in healthy subjects
3. The rise of neuropsychopharmacology: Impact on basic and clinical neuroscience
4. Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-metatyramine
5. Behavioral inhibition, behavioral activation and affective responses to impending reward and punishment: The BIS/BAS scales
6. A systematic method for clinical description and classification of personality variants: A proposal
7. Suboptimal use of anti-depressants in the treatment of depression
8. Do noradrenaline and serotonin differentially affect social motivation and behaviour?
9. Changes in personality traits during treatment with sertraline or citalopram
10. D2 dopamine receptors and personality traits
11. Experimental and clinical activity of anti-depressant drugs
12. The assessment of outcome in depression. Measures of social functioning
13. Antidepressant induced suicidality
14. Apathy and indifference in patients on fluvoxamine and fluoxetine
15. Temperament predicts clomipramine and desipramine response in major depression
16. Diagnose und Therapie der Depressionen für Praktiker
17. Selective alteration of personality and social behaviour by serotonergic intervention
18. A multitrait-multimethod examination of affect structure: Hedonic level and emotional intensity
19. Reboxetine: A double-blind comparison with fluoxetine in major depressive disorder
20. Drug profiling by computed electroencephalography and brain maps with special consideration of sertraline and its psychometric effects
21. On central effects of serotonin reuptake inhibitors: Quantitative EEG and psychometric studies with Zoloft and zimelidine
22. Temperament traits associated with platelet MAO activity
23. Cardiovascular and psychomotor effects of repeated doses of paroxetine: A comparison with amitriptyline and placebo in healthy men
24. The development and validation of brief measures of positive and negative affect